Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project

Singla,S.,Ribeiro,A.,Torgutalp,M.,Mease,P. J.,Proft,F.

DOI: https://doi.org/10.1136/rmdopen-2023-003809

2024-01-10

RMD Open

Abstract:Background Psoriatic arthritis (PsA) is a multifaceted condition with a broad spectrum of manifestations and a range of associated comorbidities. A notable segment of patients with PsA remains resistant to even advanced therapeutic interventions. This resistance stems from myriad causes, including inflammatory and non-inflammatory factors. Objectives To collate and critically assess the various definitions and criteria of difficult-to-treat (D2T PsA present in the literature. Methods Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines, we conducted a scoping review in July 2023, searching PubMed, American College of Rheumatology Convergence 2022, European Alliance of Associations for Rheumatology Congress 2023, Google Scholar and cited articles. Selection was made by two independent authors using Rayyan software, and conflicts were adjudicated by a third author. Eligibility criteria for PubMed focused on all article designs that were written in English, with full-text available, from the past decade, excluding only those not defining D2T PsA or targeting other populations. Results From the 565 references sourced, 15 studies were analysed, revealing considerable variations in defining both 'active disease' and 'resistant PsA', which was most often termed 'D2T' PsA. Conclusion The definitions and criteria for D2T PsA and for 'active disease' are notably heterogeneous, with considerable variation across sources. The ongoing Group for Research and Assessment of Psoriasis and Psoriatic Arthritis initiative stands to bridge these definitional gaps and aims to provide guidance for clinicians and illuminate a path for pharmaceuticals and regulatory agencies to follow.

rheumatology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to define and standardize "difficult - to - treat psoriatic arthritis" (D2T PsA). Specifically, the researchers found that currently, there are significant heterogeneities in the definitions and criteria of D2T PsA in the literature. This inconsistency not only affects clinicians' treatment decisions for patients but also hinders the development of clinical trials designed for this specific patient group. Therefore, this review aims to systematically collect and evaluate various definitions and criteria in the existing literature, providing a basis for subsequent research and clinical practice, especially to support a Delphi study being carried out by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), which aims to develop a widely - accepted D2T PsA definition.

The main objectives of the study include:
1. **Sorting and critical assessment**: Various definitions and criteria of D2T PsA in the literature.
2. **Revealing the diversity of definitions**: There are significant differences in the definitions of "active disease" and "difficult - to - treat psoriatic arthritis" in current research.
3. **Providing a basis for future research**: By providing data support, help GRAPPA's Delphi study develop a data - driven and expert - opinion - supported D2T PsA definition.

The achievement of these objectives will help improve the clinical management and treatment outcomes of patients with difficult - to - treat psoriatic arthritis, and at the same time promote the research and application of new therapies.